Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
Recruiting now · Not applicable
Conditions studied: Smoking Cessation, Smoking, Physician's Role
In brief
This study evaluates the feasibility and preliminary effects of precision tobacco treatment, compared to usual care, on promoting tobacco treatment in oncology patients and providers in the oncology care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This intervention may increase patient receipt of tobacco treatment, patient medication use, and patient smoking abstinence at 6 months.
Key facts
- Study ID
- NCT07166120
- Run by
- Washington University School of Medicine
- People needed
- 132
- Starts
- 2025-09-11
- Expected to finish
- 2027-09-30
- Last updated by the study team
- 2026-07-24
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
Where it is running
- John Cochran Veteran's Affairs Medical Center — St Louis, Missouri, United States (enrolling)
- Washington University School of Medicine — St Louis, Missouri, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.